Moneycontrol PRO
HomeNewsIndiaIn Charts | COVID-19 cases and vaccination: India vs other countries

In Charts | COVID-19 cases and vaccination: India vs other countries

India hit the landmark figure of 1 billion COVID-19 vaccinations administered on October 21. Here’s how India fares in fighting the pandemic.

October 21, 2021 / 17:24 IST
Representational Image

India administered 1 billion (100 crore) COVID-19 vaccine doses on October 21 in a span of just over nine months, a commendable feat for a country with a 1.3 billion population scattered far and wide, including some of the most remote places. The efforts of healthcare workers and vaccinators have been lauded by all, including Prime Minister Narendra Modi.


Since the pandemic, India has reported over 34 million COVID-19 cases and 452,811 deaths. More than 33 million people have recovered, as per the October 21 update.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India currently has 178,831 active COVID-19 cases, or 1 percent of the global active case load, whereas the US accounts for 54 percent, the most. In terms of cases and deaths per million, too, India fares better than some other countries. The number of vaccine doses administered by India are currently 2x that of the US, 5x that of Japan and 9x that of Germany.

It took India 278 days starting January 16 to administer 1 billion jabs. More than 50 percent of the adult population have got the first dose and over 21 percent have received both doses. The landmark figure was crossed despite the challenges of a large population and people living in remote areas. The efforts put in by healthcare workers and vaccinators in reaching such locations have been commendable.

Here’s how India fares compared with others on COVID-19:







Moneycontrol News
first published: Oct 21, 2021 05:24 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347